Search Results 681-690 of 16990 for pharmacogenetics
The purpose of this study is to: Prospectively characterize the dynamic systemic hemodynamic changes that occur during dynamic CT myelography. Prospectively ...
The Harris lab is investigating several types of kidney conditions. Autosomal dominant polycystic kidney disease (ADPKD). Our studies of ADPKD focus on genetic ...
This study is designed to determine whether or not plasma and sputum microRNA might be an effective, non-invasive biomarker for lung cancer risk. More ...
clinicaltrials gov.
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
About this study. New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous.
Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...
About this study. The objectives of this study are to characterize the endocrine phenome of 60 patients with PMM2-CDG through a cross-sectional measurement ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.